N-(3,4-Dichlorophenyl)-2-oxo-2-(2-(3,4,5-trimethoxybenzylidene)hydrazinyl)acetamide

Catalog No. :
ACVYKT835
CAS No. :
765274-40-6
Molecular Formula :
C18H17Cl2N3O5
Molecular Weight :
426.26

IUPAC Name:(E)-N-(3,4-dichlorophenyl)-2-oxo-2-(2-(3,4,5-trimethoxybenzylidene)hydrazineyl)acetamide

N-(3,4-Dichlorophenyl)-2-oxo-2-(2-(3,4,5-trimethoxybenzylidene)hydrazinyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3,4-Dichlorophenyl)-2-oxo-2-(2-(3,4,5-trimethoxybenzylidene)hydrazinyl)acetamide
IUPAC Name(E)-N-(3,4-dichlorophenyl)-2-oxo-2-(2-(3,4,5-trimethoxybenzylidene)hydrazineyl)acetamide
MDL No.MFCD00830796
Molecular FormulaC18H17Cl2N3O5
Molecular Weight426.26
SMILESO=C(NC1=CC=C(Cl)C(Cl)=C1)C(N/N=C/C2=CC(OC)=C(OC)C(OC)=C2)=O
InChI KeyZMMUHLHVALSQRC-ZVBGSRNCSA-N
SynonymSALOR-INT L456292-1EA;N-(3,4-DICHLORO-PH)-2-OXO-2-(2-(3,4,5-TRIMETHOXYBENZYLIDENE)HYDRAZINO)ACETAMIDE
CAS No.765274-40-6

Safety Data

Pictogram
Harmful or irritantHealth hazardEnvironmental hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H319-H332-H372-H400
Precautionary Statement(s)
P260-P264-P270-P273-P280-P301+P312+P330-P304+P312-P305+P351+P338-P314-P337+P313-P391-P501

Synthetic Route by SureRoute

1. ACVYKT835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVYKT835 route product structure diagram
    ACVYKT835765274-40-6
Inquiry

2. ACVYKT835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVYKT835 route product structure diagram
    ACVYKT835765274-40-6
Inquiry

Comments (0)